Opdivo (nivolumab)

pCPA File Number: 20933

Negotiation Status:

Concluded with an LOI

Indication(s):

Squamos Cell Carcinoma of the Head and Neck

Sponsor/Manufacturer:

Bristol Myers Squibb Canada Inc.

CADTH Project Number:

pCODR 10095

pCPA Engagement Letter Issued:

2017-09-29

Negotiation Process Concluded:

2017-11-20